QUEBEC CITY – Senior administration of SiliCycle is happy to have taken a brand new step in the direction of the commercialization of purified extracts of varied cannabinoids with the obtention of its hashish processing license from Health Canada. The Quebec-based firm can thus transfer ahead to remodel the biomass of hemp and hashish into pure, high-quality extracts.

The authorization supplied by Health Canada permits SiliCycle to start out manufacturing -at its new plant – positioned in Quebec City, which was accomplished in early 2020. More than 22 million {dollars} have been invested in building and gear acquisition prices associated to finishing up the extraction, purification and packaging processes utilized by the corporate and its affiliate PurCann Pharma, which is devoted to this subject of experience.

“There is certainly a craze for the production of cannabinoids, but the interest lies particularly in the ability to offer these substances in their pure form – This is precisely where we set ourselves apart with processes that allow us to produce the desired quantities and proportions in a stable and reproducible manner despite the variations -in the biomass. This is how we will be able to provide customers with -reliable products, an essential condition for commercial success,” stated SiliCycle President Hugo St-Laurent.

The new plant will course of as much as 100,000 kg of biomass per 12 months, thus offering SiliCycle with the instruments to supply hundreds of kilograms of extracts – with various levels of purity in line with the wants of its prospects. The new plant can also be outfitted with models for the preparation of completed merchandise together with tinctures, sprays and so forth, to fulfill buyer wants.

“We are applying all the expertise acquired in the pharmaceutical field to ensure product quality and reproducibility according to very high standards. Our scientific approach is therefore rigorous and proven, combined with the quality of our new facilities and the presence of high-caliber researchers within our team, thus we are well positioned to successfully market our products”, stated Pierre Plante, Vice President – Operations for PurCann Pharma.

About SiliCycle Inc.
Founded in 1995, SiliCycle Inc. is a worldwide chief within the growth, the manufacturing and the commercialization of excessive worth silica-based and specialty merchandise for chromatography, analytical and natural chemistry. Our enterprise extends to greater than fifty nations and our buyer portfolio consists of corporations within the pharmaceutical and biopharmaceutical industries, contract analysis and manufacturing organizations in addition to college laboratories, hospital analysis facilities, agriculture and meals, environmental, petrochemicals, and industrial course of corporations. Our supply consists of amongst others companies:

  • Aqueous or natural extraction of varied molecules from numerous biomasses
  • Customized purification of the dimensions from laboratory to industrial
  • Development of analytical strategies to realize the specified ranges of purity
  • Synthesis of molecules of curiosity
  • Production of lively components resembling omega-3s, polyphenols and CBD / THC molecules

About PurCann Pharma
PurCann Pharma is specialised within the manufacturing and commercialization of cannabinoid-rich extracts from hemp and hashish grown in Canada. A good portion of those biomasses is licensed Organic. The purified and standardized extracts wealthy in CBD and / or THC are bought in bulk or as completed merchandise, resembling tinctures, sprays, softgels. PurCann Pharma additionally presents R&D, extraction, purification and packaging companies.

Source link